12 Bleeding Pattern Variations That Signal Clotting and Platelet Disorders

8. Excessive Menstrual Bleeding - The Gender-Specific Bleeding Disorder Indicator

Excessive menstrual bleeding, medically termed menorrhagia, represents a critical bleeding pattern that affects a significant proportion of women with underlying bleeding disorders, serving as both a diagnostic clue and a major source of morbidity that can significantly impact quality of life and overall health status. Heavy menstrual bleeding is defined as menstrual flow lasting longer than seven days, requiring change of sanitary protection every hour for several consecutive hours, flooding or gushing of flow, bleeding between periods, or passage of clots larger than a quarter, though these criteria must be interpreted in the context of individual baseline patterns. The prevalence of bleeding disorders among women presenting with heavy menstrual bleeding is substantially higher than in the general population, with studies indicating that 10-20% of women with menorrhagia have an underlying hemostatic disorder, most commonly von Willebrand disease, platelet function disorders, or mild factor deficiencies. The pathophysiology of excessive menstrual bleeding in bleeding disorders involves inadequate hemostasis at the level of the spiral arteries in the endometrium during menstruation, where normal clot formation and stabilization are essential for controlling blood loss as the functional layer of the endometrium is shed. The impact of menorrhagia extends beyond the bleeding episodes themselves, often leading to iron deficiency anemia, fatigue, decreased exercise tolerance, and significant interference with daily activities, work, and social functioning. Evaluation of women with excessive menstrual bleeding should include comprehensive bleeding history, assessment of menstrual patterns using standardized tools, laboratory evaluation including complete blood count, iron studies, and coagulation studies, with consideration of specialized testing for von Willebrand disease and platelet function disorders when indicated by clinical presentation or family history.